Advanced Solid Tumors: AMG 355 Treatment Study

We are exploring a new treatment called AMG 355, both alone and with Pembrolizumab, for individuals with advanced solid tumors. This study aims to assess its safety and potential effectiveness.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Institut Bergonie
Oncologie medicale
Bordeaux, France
Institut Gustave Roussy
Departement de Medecine oncologique
Villejuif, France
Stichting Radboud University Medical Center
Department of Medical Oncology
Nijmegen, Netherlands

Sponsor: Amgen Inc.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.